Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 21 (2) , 204-210
- https://doi.org/10.1016/s0168-8278(05)80396-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Hepatitis B virus reinfection after orthotopic liver transplantation: Serological and clinical implicationsJournal of Hepatology, 1992
- Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-αJournal of Hepatology, 1991
- Liver transplantation in HBs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunizationJournal of Hepatology, 1991
- Passive immunoprophylaxis after liver transplantation in HBsAg-positive patientsThe Lancet, 1991
- Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitisHepatology, 1991
- PERSISTENT HEPATITIS B VIRUS INFECTION OF MONONUCLEAR BLOOD CELLS WITHOUT CONCOMITANT LIVER INFECTIONTransplantation, 1990
- Hepatitis b virus replication in acute hepatitis B, acute hepatitis B virus-hepatitis delta virus coinfection and acute hepatitis delta superinfectionHepatology, 1987
- Quantitation of hepatitis B virus dna (HBV DNA) in serum using the spot hybridization technique and scintillation countingJournal of Virological Methods, 1985